NO152509C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser

Info

Publication number
NO152509C
NO152509C NO752983A NO752983A NO152509C NO 152509 C NO152509 C NO 152509C NO 752983 A NO752983 A NO 752983A NO 752983 A NO752983 A NO 752983A NO 152509 C NO152509 C NO 152509C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
cephalosporine compounds
cephalosporine
Prior art date
Application number
NO752983A
Other languages
English (en)
Norwegian (no)
Other versions
NO152509B (no
NO752983L (fi
Inventor
William J Gottstein
Murray A Kaplan
Alphonse P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO752983L publication Critical patent/NO752983L/no
Priority to NO76762751A priority Critical patent/NO152699C/no
Priority to NO85851437A priority patent/NO158942C/no
Publication of NO152509B publication Critical patent/NO152509B/no
Publication of NO152509C publication Critical patent/NO152509C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO752983A 1974-09-03 1975-09-01 Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser NO152509C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO76762751A NO152699C (no) 1974-09-03 1976-08-09 7-aminocephalosporinforbindelse for anvendelse som7-aminocephalosporinforbindelse for anvendelse som utgangsmateriale ved fremstilling av terapeutisk utgangsmateriale ved fremstilling av terapeutisk virksomme cephalosporiner virksomme cephalosporiner
NO85851437A NO158942C (no) 1974-09-03 1985-04-11 7-aminocephalosporinforbindelse for anvendelse som utgangsmateriale ved fremstilling av terapeutisk virksomme cephalosporiner.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50299174A 1974-09-03 1974-09-03
US05/590,971 US4297489A (en) 1974-09-03 1975-06-27 7-α-Amino-substituted acylamino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids

Publications (3)

Publication Number Publication Date
NO752983L NO752983L (fi) 1976-03-04
NO152509B NO152509B (no) 1985-07-01
NO152509C true NO152509C (no) 1985-10-09

Family

ID=27054342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752983A NO152509C (no) 1974-09-03 1975-09-01 Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser

Country Status (21)

Country Link
US (1) US4297489A (fi)
JP (1) JPS6150956B2 (fi)
AR (1) AR222771A1 (fi)
BG (1) BG27091A3 (fi)
CA (4) CA1135255A (fi)
CH (1) CH636882A5 (fi)
DD (2) DD123471A5 (fi)
DE (2) DE2560655C2 (fi)
DK (4) DK145262C (fi)
ES (2) ES440707A1 (fi)
FI (1) FI62841C (fi)
FR (1) FR2283686A1 (fi)
HU (1) HU169490B (fi)
IE (1) IE43123B1 (fi)
IL (1) IL48020A (fi)
LU (1) LU73306A1 (fi)
NL (1) NL161758C (fi)
NO (1) NO152509C (fi)
OA (1) OA05096A (fi)
SE (3) SE431548B (fi)
YU (5) YU213275A (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
US4101656A (en) * 1976-07-12 1978-07-18 Smithkline Corporation 7β-Acylamino-3-(alkanesulfonamidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
DE2724092A1 (de) * 1977-05-27 1978-12-07 Smithkline Corp Cephalosporine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
US4243803A (en) * 1979-07-05 1981-01-06 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US4374994A (en) * 1979-07-05 1983-02-22 Bristol-Myers Company Process for preparation of 5-mercaptotetrazolyl-1-acetic acid
EP0095029B1 (en) * 1979-11-30 1986-11-05 Fujisawa Pharmaceutical Co., Ltd. 5-thio-tetrazol compounds and their preparation
JPS56158791A (en) * 1980-05-10 1981-12-07 Taisho Pharmaceut Co Ltd Cephalosporin compound
IL63767A0 (en) * 1980-09-17 1981-12-31 Lilly Co Eli Cephalosporin compounds
JPS57188594A (en) * 1981-05-15 1982-11-19 Eisai Co Ltd Preparation of 7-(2-amino-2-phenylacetamido)cephem derivative
US4448958A (en) * 1982-10-20 1984-05-15 Bristol-Myers Company Purification of ceforanide
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
DE3641822A1 (de) * 1986-12-06 1988-06-16 Goedecke Ag Verwendung von dihydrophenylaminosaeurederivaten und diese enthaltende arzneimittel zur immunmodulation und cytostase

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819623A (en) * 1968-04-12 1974-06-25 Fujisawa Pharmaceutical Co 3,7-disubstituted cephalosporin compounds
DE1953861C2 (de) * 1969-10-25 1982-12-23 Fujisawa Pharmaceutical Co., Ltd., Osaka 7-Tetrazolylacetamido-3-thiomethyl-3-cephem-4- carbonsäuren
US3814755A (en) * 1972-08-30 1974-06-04 Bristol Myers Co 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
GB1478055A (en) 1973-07-27 1977-06-29 Erba Carlo Spa Cephalosporin compounds
US4074929A (en) 1973-08-29 1978-02-21 Amp Incorporated Cable card edge connector
NL7414119A (nl) * 1973-10-31 1975-05-02 Fujisawa Pharmaceutical Co Werkwijze ter bereiding van 1h-tetrazool-5-thiol- derivaten en 1-gesubstitueerde 1h-tetrazool- -5-thiolen.
US4205166A (en) * 1974-02-20 1980-05-27 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted-3-aminoalkyl-, acylaminoalkyl-, or hydroxyalkyl-substituted heterocyclic thiomethyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
US4092476A (en) * 1974-02-21 1978-05-30 Beecham Group Limited Phthalidyl esters of 7-[(α amino, 2 substituted acetamido)-3-(heterocyclic-thio methyl)]cephalosporins
US4068074A (en) * 1974-04-05 1978-01-10 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin derivatives having at the 3-position of the cephem ring a heterocyclic thiomethyl group with a carboxy or sulfo group and at the 7-position of the cephem ring an α-heterocylic acylaminophenyl-acetamide group
US4160086A (en) * 1974-04-27 1979-07-03 Beecham Group Limited 3-Heterocyclicthio-7-α-carboxy 2-aryl acetamido cephalosporanic acid
JPS612674B2 (fi) * 1974-06-20 1986-01-27 Meiji Seika Co
US4182863A (en) * 1974-09-03 1980-01-08 Bristol-Myers Company 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US4172196A (en) * 1974-09-03 1979-10-23 Bristol-Myers Company Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
US4183925A (en) * 1975-03-27 1980-01-15 Pfizer Inc. 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use
JPS525787A (en) * 1975-06-27 1977-01-17 Bristol Myers Co Antiibacterial agent
US4013648A (en) * 1975-07-23 1977-03-22 Bristol-Myers Company Δ2,3 -0-2-Isocephem-4-carboxylic acid and derivatives as antibacterial agents
US4220644A (en) * 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
US4118563A (en) * 1977-11-25 1978-10-03 Bristol-Myers Company Production of 7-(2-aminomethylphenylacetamido-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
NL161758C (nl) 1980-03-17
DK240582A (da) 1982-05-27
FI752434A (fi) 1976-03-04
ES457998A1 (es) 1978-03-01
SE7907672L (sv) 1979-09-14
NO152509B (no) 1985-07-01
SE435279B (sv) 1984-09-17
YU213275A (en) 1982-02-28
IL48020A0 (en) 1975-11-25
FR2283686A1 (fr) 1976-04-02
YU44669B (en) 1990-12-31
CH636882A5 (de) 1983-06-30
SE7509702L (sv) 1976-03-04
FR2283686B1 (fi) 1983-07-08
SE8305539D0 (sv) 1983-10-07
DK162388B (da) 1991-10-21
NO752983L (fi) 1976-03-04
LU73306A1 (fi) 1976-08-13
DK423383D0 (da) 1983-09-16
YU44964B (en) 1991-06-30
HU169490B (fi) 1976-12-28
DD130787A5 (de) 1978-05-03
DD123471A5 (fi) 1976-12-20
IL48020A (en) 1982-02-28
DK148796B (da) 1985-09-30
FI62841C (fi) 1983-03-10
YU223081A (en) 1983-12-31
OA05096A (fr) 1981-01-31
DK147483B (da) 1984-08-27
SE8305539L (sv) 1983-10-07
JPS5154580A (fi) 1976-05-13
FI62841B (fi) 1982-11-30
DK145262B (da) 1982-10-18
DE2560655C2 (fi) 1988-07-14
US4297489A (en) 1981-10-27
CA1135254A (en) 1982-11-09
CA1123840A (en) 1982-05-18
BG27091A3 (bg) 1979-08-15
DK367279A (da) 1979-08-31
DK423383A (da) 1983-09-16
DK391075A (da) 1976-03-04
SE453507B (sv) 1988-02-08
NL7510391A (nl) 1976-03-05
DE2538804A1 (de) 1976-07-15
IE43123B1 (en) 1980-12-31
IE43123L (en) 1976-03-03
DK148796C (da) 1986-03-17
JPS6150956B2 (fi) 1986-11-06
ES440707A1 (es) 1977-07-01
DK162388C (da) 1992-03-16
CA1135256A (en) 1982-11-09
CA1135255A (en) 1982-11-09
DK147483C (da) 1985-03-25
DE2538804C2 (de) 1986-10-16
DK145262C (da) 1983-03-14
AR222771A1 (es) 1981-06-30
SE431548B (sv) 1984-02-13
YU223381A (en) 1983-06-30
YU223281A (en) 1983-12-31
YU44833B (en) 1991-04-30
YU223181A (en) 1983-12-31

Similar Documents

Publication Publication Date Title
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO157933C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO142401C (no) Analogifremgangsmaate til fremstilling av mavesyresekresjonshemmende 2-pyridylalkyltiobenzimidazoler
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO152509C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cephalosporinforbindelser
NO146096C (no) Analogifremgangsmaate ved fremstilling av thienothiazinderivater
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
SE426830B (sv) Forfarande for framstellning av cefalosporinforeningar
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO143664C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser
NO144604C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme histidinderivater
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
NO142907C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme fenylalkylaminer
NO145197C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfolinforbindelser
NO145982C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme monokromon-forbindelser
NO143501C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksom benzopyranforbindelse
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
NO142035C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme substituerte triazoler
SE431337B (sv) Forfarande for framstellning av cefalosporinforeningar.